Hepatitis B virus enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cytotoxicity by increasing TRAIL-R1/death receptor 4 expression

Journal of Hepatology

Volumn 39, Issue 3, 2003, Pages 414-420

  Janssen, Harry L A ^a,b   Higuchi, Hajime ^b   Abdulkarim, Ahmad ^b   Gores, Gregory J ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; Lamivudine

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE; CASPASE INHIBITOR; LAMIVUDINE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ARTICLE; CELL KILLING; CELL STRAIN HEPG2; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; GENETIC TRANSFECTION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; VIRUS REPLICATION;

EID: 0042329166     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(03)00265-4     Document Type: Article

References (26)

1. Galle PR, Hofmann WJ, Walczak H, Schaller H, Otto G, Stremmel W, et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 1995;182:1223-1230.
2. Kagi D, Vignaux F, Ledermann B, Burki K, Depraetere V, Nagata S, et al. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 1994;265:528-530.
3. Mochizuki K, Hayashi N, Hiramatsu N, Katayama K, Kawanishi Y, Kasahara A, et al. Fas antigen expression in liver tissues of patients with chronic hepatitis B. J Hepatol 1996;24:1-7.
4. Fang JW, Shen WW, Meager A, Lau JY. Activation of the tumor necrosis factor-alpha system in the liver in chronic hepatitis B virus infection. Am J Gastroenterol 1996;91:748-753.
5. Jo M, Kim TH, Seol DW, Esplen JE, Dorko K, Billiar TR, et al. Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand. Nat Med 2000;6:564-567.
6. Yamanaka T, Shiraki K, Sugimoto K, Ito T, Fujikawa K, ho M, et al. Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines. Hepatology 2000;32:482-490.
7. French LE, Tschopp J. The TRAIL to selective tumor death. Nat Med 1999:5:146-147.
8. Sato K, Hida S, Takayanagi H, Yokochi T, Kayagaki N, Takeda K, et al. Antiviral response by natural killer cells through TRAIL gene induction by IFN-alpha/beta. Eur J Immunol 2001;31:3138-3146.
9. Sells MA, Zelent AZ, Shvartsman M, Acs G. Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions. J Virol 1988;62:2836-2844.
10. Schneider P. Production of recombinant TRAIL and TRAIL receptor: Fc chimeric proteins. Methods Enzymol 2000;322:325-345.
11. Higuchi H, Bronk SF, Taniai M, Canbay A, Gores GJ. Cholestasis increases tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-R2/DR5 expression and sensitizes the liver to TRAIL-mediated cytotoxicity. J Pharmacol Exp Ther 2002;303:461-467.
12. Higuchi H, Yoon JH, Grambihler A, Werneberg N, Bronk SF, Gores GJ. Bile acids stimulate cFLIP phosphorylation enhancing TRAIL-mediated apoptosis. J Biol Chem 2003;278:454-461.
13. Kwo P, Patel T, Bronk SF, Gores GJ. Nuclear serine protease activity contributes to bile acid-induced apoptosis in hepatocytes. Am J Physiol 1995;268:G613-G621.
14. Kruining J, Heijtink RA, Schalmn SW. Antiviral agents in hepatitis B virus transfected cell lines: inhibitory and cytotoxic effect related to time of treatment. J Hepatol 1995;22:263-267.
15. Pas SD, Fries E, De Man RA, Osterhaus AD, Niesters HG. Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays. J Clin Microbiol 2000;38:2897-2901.
16. Seto E, Mitchell PJ, Yen TS. Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors. Nature 1990;344:72-74.
17. Gores GJ, Kaufmann SH. Is TRAIL hepatotoxic? Hepatology 2001;34:3-6.
18. Higuchi H, Bronk SF, Takikawa Y, Werneburg NW, Takimoto R, El-Deity W, et al. The bile acid glycochenodeoxycholate induces TRAIL-receptor 2/DR5 expression and apoptosis. J Biol Chem 2001;15:15.
19. Mundt B, Waithemate M, Kuhnel F, Zender L, Paul Y, Tilmann H, et al. Infected hepatocytes are selectively eliminated by TRAIL in viral hepatitis. J Hepatol 2002;36:A91.
20. Han L, Sun W, Ma C, Zhang L, Cao Y, Song J, et al. The influence of HBV infection on TRAIL-induced apoptosis and its mechanism. Zhonghua Yi Xue Za Zhi 2002;82:597-600.
21. Sedger LM, Shows DM, Blanton RA, Peschon JJ, Goodwin RG, Cosman D, et al. IFN-gamma mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression. J Immunol 1999;163:920-926.
22. Strater J, Walczak H, Pukrop T, Von Muller L, Hasel C, Kornmann M. et al. TRAIL and its receptors in the colonic epithelium: a putative role in the defense of viral infections. Gastroenterology 2002;122:659-666.
23. Lum JJ, Pilon AA, Sanchez-Dardon J, Phenix BN, Kim JE, Mihowich J, et al. Induction of cell death in human immunodeficiency virus-infected macrophages and resting memory CD4 T cells by TRAIL/Apo21. J Virol 2001;75:11128-11136.
24. Kim H, Lee H, Yun Y. X-gene product of hepatitis B virus induces apoptosis in liver cells. J Biol Chem 1998;273:381-385.
25. Chirillo P, Pagano S, Natoli G, Pun PL, Burgio VL, Balsano C, et al. The hepatitis B virus X gene induces p53-mediated programmed cell death. Proc Natl Acad Sci USA 1997;94:8162-8167.
26. Canhay A, Higuchi H, Bronk SF, Taniai M, Sebo TJ, Gores GJ. Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis. Gastroenterology 2002;123:1323-1330.